Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/14238
Title: | Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium | Authors: | Van Heirstraeten, Liesbet Coenen, Samuel Lammens, Christine HENS, Niel Goossens, Herman Malhotra-Kumar, Surbhi |
Issue Date: | 2012 | Publisher: | CENTERS DISEASE CONTROL | Source: | EMERGING INFECTIOUS DISEASES, 18 (9), p. 1515-1518 | Abstract: | In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997-2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999-2009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs. | Notes: | Malhotra-Kumar, S (reprint author),[Van Heirstraeten, Liesbet; Coenen, Samuel; Lammens, Christine; Hens, Niel; Goossens, Herman; Malhotra-Kumar, Surbhi] Univ Antwerp, B-2020 Antwerp, Belgium. [Hens, Niel] Univ Hasselt, Hasselt, Belgium. surbhi.malhotra@ua.ac.be | Keywords: | Immunology; Infectious Diseases | Document URI: | http://hdl.handle.net/1942/14238 | ISSN: | 1080-6040 | e-ISSN: | 1080-6059 | DOI: | 10.3201/eid1809.120049 | ISI #: | 000307989700024 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2013 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Antimicrobial drug use and macrolide-resistant streptococcus pyogenes, Belgium.pdf | Published version | 312.48 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
24
checked on Sep 5, 2020
WEB OF SCIENCETM
Citations
29
checked on Oct 12, 2024
Page view(s)
64
checked on Sep 7, 2022
Download(s)
104
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.